Outlook Therapeutics (OTLK) Q1 2025 Earnings

14FebConfirmed
Q2 2024
Q3 2024
Q4 2024
Q1 2025
-1.55
-1.29
-1.02
-0.76

Details

Expected EPS
-0.76
Actual EPS
-0.89
Surprise EPS
-0.13
Surprise Percent
+17.11%

Description

Outlook Therapeutics (OTLK) has reported earnings of -0.89 per share for Q1 2025.

0 Comments

Share your thoughts